2110 NARCISSUS CT, VENICE, CA
Market cap: $5.3M (2/12/2026)
Price: $0.71
Stockholders Approve Amendment to 2023 Stock Incentive Plan
Other Events
Announces Closing of $60 Million Public Offering of Common Stock
Reg. FD, Other Events
Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
Changes in Board, Management or Compensation
Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
News, Material Contracts
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement